The FDA gives the green light to the first gene therapy for deafness
The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical milestone.
Original Source
Read the full article at Npr →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.